Is Coromandel Engg. overvalued or undervalued?
As of August 20, 2025, Coromandel Engineering is considered overvalued with a PE ratio of 83.69 and significantly higher valuation metrics compared to peers like Larsen & Toubro, despite impressive stock returns of 198.62% over the past five years.
As of 20 August 2025, the valuation grade for Coromandel Engineering has moved from risky to does not qualify, indicating a significant shift in its assessment. The company is currently considered overvalued, with a PE ratio of 83.69, a Price to Book Value of 18.38, and an EV to EBITDA of 41.00. These ratios suggest that the stock is trading at a premium compared to its earnings and book value.In comparison to its peers, Coromandel's valuation metrics are notably higher; for instance, Larsen & Toubro has a PE ratio of 31.88 and an EV to EBITDA of 16.62, which underscores the disparity in valuation. Other peers like Siemens and CG Power & Ind are also trading at lower multiples, reinforcing the notion that Coromandel is overvalued in its industry. Additionally, while Coromandel has shown impressive stock returns over the past five years at 198.62%, this does not align with its current valuation metrics, further supporting the conclusion of overvaluation.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
